Trump Targets Fertilizer Plant to Tighten Screws on Maduro

One of Venezuela's most valuable overseas assets is set to lose a license that allows it to operate in Colombia, amid a US attack on the finances of the Nicolas Maduro regime.
As a Venezuelan state-owned asset, fertilizer plant Monómeros Colombo Venezolanos was subject to US sanctions after 2019. Shortly after, the US Treasury issued a license allowing it to sell its products, and engage in financial transactions, including subsidiaries engaged in port services.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Yahoo

40 minutes ago

• Yahoo

EZCORP Expands in Mexico with 40-Store Acquisition

EZCORP, Inc. (NASDAQ:EZPW) is among the best small company stocks to invest in. EZCORP, Inc. (NASDAQ:EZPW), with a market capitalization of $811.591 million, has announced the acquisition of 40 pawn stores across 13 Mexican states in a press release. This attempt to expand its global footprint positions the company well in the auto pawn segment, which is considered one of the fastest-growing sectors in Mexico's pawn industry. The purchased stores, functioning under the Monte Providencia and Tu Empeño Efectivo brands, provide conventional pawn loans and auto pawn transactions. EZCORP, Inc. (NASDAQ:EZPW) assumed control of the management of seven additional Monte Providencia stores, with the anticipated completion of the purchase in the months ahead. An employee in a pawn store, counting jewelry and consumer electronics that were pawned. One of the company's standout strengths is its robust liquidity position, which has current assets exceeding short-term liabilities by a factor of four. This allows the giant to engage in more strategic transactions. Just recently, EZCORP, Inc. (NASDAQ:EZPW) declared investments worth SEK 95 billion in Swedish AI infrastructure, marking it one of the largest AI investments by the alternative asset manager in Europe. EZCORP, Inc. (NASDAQ:EZPW) is a Texas-based provider of pawn services in the United States and Latin America. With three main segments: U.S. Pawn, Latin America Pawn, and Other Investments, the company offers pawn loans and retails merchandise. Incorporated in 1989, the small-cap company is the go-to choice for short-term cash needs and quality pre-owned goods. While we acknowledge the potential of EZPW as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Yahoo

3 hours ago

• Yahoo

UnitedHealth Group (NYSE:UNH) Announces Debt Financing Totalling US$3 Billion

UnitedHealth Group recently completed a substantial debt financing deal, raising $3 billion through the issuance of various Notes. This move comes amid a period of legal settlements, such as the $69 million ERISA case, and operational restructuring, including exploring bids for its Latin American operations. Despite these significant developments, the company's stock price remained relatively flat over the last month, reflecting broader market trends which also showed minimal movement. The dividend increase and shareholder discussions on executive compensation may have subtly influenced sentiment, but overall, these events seemed to align with the market's flat performance. UnitedHealth Group has 1 possible red flag we think you should know about. Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit. UnitedHealth Group's recent $3 billion debt financing and restructuring efforts, such as evaluating bids for its Latin American operations, are significant developments. While the near-term stock price remained relatively stable amid these changes, over the past five years, the company's total shareholder return, including dividends, was 13.61%. This reflects a steady growth trajectory, although in the last year, UnitedHealth underperformed the US Healthcare industry. The current share price sees a slight discount from the analyst consensus price target of $547.65, which is 28% higher than the present value. Despite recent legal settlements and compensation discussions, the company's aggressive push towards digital tools and Medicare adjustments might bolster future earnings and revenue. UnitedHealth's projected earnings per share and revenue growth is positioned slightly behind broader market expectations over the next few years, yet planned improvements in operational efficiencies could bridge this gap over time. Learn about UnitedHealth Group's future growth trajectory here. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:UNH. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Yahoo

6 hours ago

• Yahoo

Mizuho Increases PT on Automatic Data Processing (ADP) Stock, Maintains Outperform

Automatic Data Processing, Inc. (NASDAQ:ADP) is one of the 10 software stocks analysts are upgrading. On June 13, Mizuho increased the price objective on the company's stock to $332.00 from $321.00, while maintaining an 'Outperform' rating. The firm believes that Automatic Data Processing, Inc. (NASDAQ:ADP) has done a good job over the past few years in improving product and execution. HR management team reviewing resumes on a computer. The research firm remains optimistic about Automatic Data Processing, Inc. (NASDAQ:ADP)'s future prospects as it has been introducing revamped products throughout the market segments and continues to leverage its human capital management industry-leading data and scale with tools such as AI in a bid to improve efficiencies. Automatic Data Processing, Inc. (NASDAQ:ADP)'s strategic moves, like the acquisition of PEI in Mexico, focus on enhancing its global payroll capabilities and aiding the Latin America region. With the help of integrating PEI's payroll expertise in Mexico with Automatic Data Processing, Inc. (NASDAQ:ADP)'s global reach and comprehensive HCM solutions, the focus is on enhancing the experience. For FY 2025, the company expects revenue growth of 6% – 7% and adjusted EBIT margin expansion of 40 – 50 bps. Furthermore, it anticipates diluted EPS growth of 9% – 10%. Automatic Data Processing, Inc. (NASDAQ:ADP) provides cloud-based human capital management (HCM) solutions. While we acknowledge the potential of ADP to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than ADP and that has 100x upside potential, check out our report about this cheapest AI stock. READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest in Now Disclosure: None. Sign in to access your portfolio